Evidence map›Paper›PMID 36678398›Full record

ArticlePathogens (Basel, Switzerland)2022

Evaluation of the Chagas VirClia

Isabel García-Bermejo, David Molina Arana, Gloria Zaragoza Vargas, Blanca Carrasco Fernández, Emilia García, Javier Nieto, Maria Delmans Flores-Chávez

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Evaluation of Chagas TESA VirClia assay for chronicJournal of clinical microbiology · 2026
    Article
  2. Review
  3. Article
  4. Assessment of Alinity s ChagasLife (Basel, Switzerland) · 2024
    Article
  5. Frontiers in microbiology · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Isabel García-BermejoMicrobiology Department, Hospital Universitario de Getafe, 28905 Madrid, Spain.
David Molina AranaMicrobiology Department, Hospital Universitario de Getafe, 28905 Madrid, Spain.ORCID 0000-0003-1759-395X
Gloria Zaragoza VargasMicrobiology Department, Hospital Universitario de Getafe, 28905 Madrid, Spain.
Blanca Carrasco FernándezMicrobiology Department, Hospital Universitario de Getafe, 28905 Madrid, Spain.
Emilia GarcíaLeishmaniasis and Chagas Disease Unit, National Centre for Microbiology, Instituto de Salud Carlos III, 28220 Madrid, Spain.
Javier NietoLeishmaniasis and Chagas Disease Unit, National Centre for Microbiology, Instituto de Salud Carlos III, 28220 Madrid, Spain.
Maria Delmans Flores-ChávezLeishmaniasis and Chagas Disease Unit, National Centre for Microbiology, Instituto de Salud Carlos III, 28220 Madrid, Spain.ORCID 0000-0003-2597-3100
Hospital Universitario de Getafe · ESInstituto de Salud Carlos III · ES

Funding

Instituto de Salud Carlos IIIMundo Sano Foundation
6 · The paper itself

Abstract

Chagas disease (CD), caused by the protozoan

Indexed as

Chagas diseasechemiluminescence immunoassayrecombinant antigenssensitivityserological diagnosisspecificityTESATrypanosoma cruzi infection

Identifiers

PMID36678398
PMCPMC9864210
OpenAlexW4313327754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.